The Bridge has an end date. Plan for it now.
The program runs through December 31, 2027 — "Bridge" is a candid name. That's not a reason to avoid it; it's a reason to start the long-term conversation with your doctor on day one, while the copay works in your favor.
Why this matters more for GLP-1s than most drugs
GLP-1 therapy is usually long-term — stopping often means regaining weight. So an eighteen-month coverage window raises a fair question: what happens in January 2028? The honest answer is that nobody knows yet. Medicare policy on weight-loss drugs could be extended, made permanent, or allowed to lapse. What you can control is having a plan for each possibility.
Five questions to ask your doctor at the first visit
- If the Bridge ends and nothing replaces it, what are my options — Part D coverage for another indication, self-pay, a lower-cost alternative, or a maintenance plan?
- How will we measure whether the medication is working well enough to justify continuing, whatever the price?
- What should we document now — starting BMI, diagnoses, response to therapy — so any future coverage process has what it needs?
- How often will we reassess side effects, dose, and safety?
- If I had to stop, what would a safe off-ramp look like?
The optimistic read
Demonstrations exist to generate evidence. If the Bridge shows that covering GLP-1s for weight management improves health without runaway costs, that strengthens the case for permanent coverage. People who enroll, follow through, and document their outcomes are — in a small way — part of that case.
Either way, the practical move is the same: if you may fit the criteria, have the conversation early. More months in the program means more benefit from the copay and more data about how the medication works for you before any decision point arrives.
Frequently asked questions
Is the Bridge permanent?
No — CMS describes it as a short-term demonstration through December 31, 2027. What follows depends on future policy.
Should I wait to start since it might end?
That's a decision for you and your clinician — though starting sooner means more time at the program copay.
Can the rules change before 2027?
Yes. We track the published criteria with a versioned changelog and update when CMS materials change.
Sources and review status: Content reviewed June 12, 2026, based on published CMS materials including the prescriber fact sheet (CMS Product No. 12235). Check current CMS materials: CMS Bridge overview, beneficiary information, provider information.